Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

OncoResponse
909 Fannin Street, Suite 2100
Houston, TX 77024
Phone: 206-805-1600
http://www.oncoresponseinc.com/

OncoResponse mines the human adaptive immune system to discover therapeutic antibodies against novel immuno-oncology targets. By identifying candidates from the immune systems of patients who have responded exceptionally well to cancer immunotherapies, OncoResponse has the potential to increase the success rate of these therapies across multiple cancer types.

Key Contact
Name
Clifford J. Stocks
Title
CEO
Funding Events

Date
Amount
Type
Investors
Valuation
05/26/16 undisclosed Series A Baxalta Ventures
undisclosed
03/10/17 $22,500,000 Series A Alexandria Real Estate Equities
ARCH Venture Partners
Canaan Partners
HT Family Office
MD Anderson
Rice University
undisclosed
09/11/18 $40,000,000 Series B Alexandria Venture Investments
ARCH Venture Partners
Canaan Partners
Helsinn Investment Fund
HT Family Office
Qatar Investment Authority
Redmile Group
RiverVest Venture Partners
William Marsh Rice University
undisclosed


Featured Reading